Insider Selling: Adtalem Global Education (NYSE:CVSA) CEO Sells $610,303.59 in Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 4,667 shares of the business’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $130.77, for a total value of $610,303.59. Following the sale, the chief executive officer owned 469,158 shares in the company, valued at approximately $61,351,791.66. The trade was a 0.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Price Performance

CVSA traded down $1.02 during trading on Friday, reaching $129.27. 195,878 shares of the company were exchanged, compared to its average volume of 365,483. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26. The company’s 50-day moving average is $128.36 and its two-hundred day moving average is $123.69. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. The company has a market cap of $4.38 billion, a price-to-earnings ratio of 18.36, a P/E/G ratio of 0.94 and a beta of 0.65.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. Adtalem Global Education had a return on equity of 20.88% and a net margin of 12.87%.The business had revenue of $501.38 million during the quarter. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS. Research analysts forecast that Adtalem Global Education Inc. will post 9 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Adtalem Global Education

A hedge fund recently bought a new position in Adtalem Global Education stock. Kendall Capital Management bought a new position in Adtalem Global Education Inc. (NYSE:CVSA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. 98.84% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the company. Wall Street Zen upgraded Adtalem Global Education from a “hold” rating to a “buy” rating in a research report on Sunday, September 27th. BMO Capital Markets cut their price objective on Adtalem Global Education from $148.00 to $145.00 and set an “outperform” rating for the company in a report on Monday. Truist Financial cut shares of Adtalem Global Education from a “buy” rating to a “hold” rating and set a $140.00 price objective on the stock. in a research report on Thursday, September 3rd. Finally, Weiss Ratings downgraded shares of Adtalem Global Education from a “hold (c+)” rating to a “hold (c)” rating in a research note on Tuesday. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Adtalem Global Education currently has an average rating of “Hold” and a consensus target price of $151.67.

Adtalem Global Education Company Profile

Adtalem Global Education is an education services company that provides professional, postsecondary and healthcare-focused education through institutions and brands serving students and working professionals. Its offerings include degree programs, career training, certification preparation and continuing education.

The company’s academic institutions include Chamberlain University, Walden University, American University of the Caribbean School of Medicine, Ross University School of Medicine, Ross University School of Veterinary Medicine and the Medical University of the Americas.